Form 4: H.B. Fuller Executive VP and CFO, John J. Corkrean, Reports Changes in Beneficial Ownership
SEC Form 4 Filing
John J. Corkrean, Executive VP and CFO of H.B. Fuller, filed a Form 4 detailing changes in his beneficial ownership of the company's stock, including the acquisition of phantom units and adjustments to stock options and restricted stock units.
Summary
- On May 12, 2025, John J. Corkrean, Executive VP and CFO of H.B. Fuller, reported changes in his beneficial ownership of the company's securities.
- The report includes the acquisition of 172.85 phantom units on May 9, 2025, which convert into shares of common stock.
- Corkrean directly owns 52,196 shares of common stock.
- He also holds various employee stock options with exercise prices ranging from $43.48 to $77.72 and expiration dates between 2026 and 2035.
- Additionally, he possesses restricted stock units that convert into common stock, vesting in annual installments.
- The report details the number of derivative securities beneficially owned following the reported transactions.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the compensation and ownership structure of the company's executives.
Key Dates
| Date | Description |
|---|---|
| 05/17/2017 | Date of employee stock option grant with an exercise price of $43.48, 100% vested, expiring on 05/17/2026. |
| 01/26/2018 | Date of employee stock option grant with an exercise price of $50.1, 100% vested, expiring on 01/26/2027. |
| 01/25/2019 | Date of employee stock option grant with an exercise price of $53.57, 100% vested, expiring on 01/25/2028. |
| 01/24/2020 | Date of employee stock option grant with an exercise price of $45.05, 100% vested, expiring on 01/24/2029. |
| 01/24/2021 | Date of employee stock option grant with an exercise price of $48.35, 100% vested, expiring on 01/24/2030. |
| 01/27/2022 | Date of employee stock option grant with an exercise price of $51.89, 100% vested, expiring on 01/27/2031. |
| 01/24/2023 | Date of employee stock option grant with an exercise price of $72.94, vesting in three annual installments, expiring on 01/24/2032. |
| 01/24/2024 | Date of employee stock option grant with an exercise price of $68.17, vesting in three annual installments, expiring on 01/24/2033. |
| 01/24/2024 | Date of restricted stock unit grant, vesting in three annual installments, expiring on 01/24/2026. |
| 01/26/2025 | Date of employee stock option grant with an exercise price of $77.72, vesting in three annual installments, expiring on 01/26/2034. |
| 01/26/2025 | Date of restricted stock unit grant, vesting in three annual installments, expiring on 01/26/2027. |
| 01/27/2026 | Date of employee stock option grant with an exercise price of $64.28, vesting in three annual installments, expiring on 01/27/2035. |
| 01/27/2026 | Date of restricted stock unit grant, vesting in three annual installments, expiring on 01/27/2028. |
| 05/09/2025 | Date of transaction: Acquisition of 172.85 phantom units. |
| 05/12/2025 | Date of Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, Executive Compensation, Stock Options, Restricted Stock Units, H.B. Fuller, FUL, Corkrean, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.